B型肝炎治療薬の世界市場：2022年～2026年

世界のB型肝炎治療薬の市場規模は、2022年～2026年の間に4億7,149万米ドルの増加が見込まれ、予測期間中に3.29%のCAGRで成長すると予測されています。

市場を牽引しているのは、乳幼児のB型肝炎の有病率の増加、B型肝炎への関心を高めるための取り組みの拡大、HBVの分子診断への需要の増大です。

当レポートでは、世界のB型肝炎治療薬市場について調査分析し、全体的な分析、市場規模と予測、動向、成長促進要因、課題、および約25社のベンダーをカバーするベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模（2021年）
• 市場の見通し：2021年～2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• ライバルの脅威
• 市況

第5章 用途別の市場セグメンテーション

• 市場セグメント
• 用途別の比較
• 薬：市場規模と予測（2021年～2026年）
• ワクチン：市場規模と予測（2021年～2026年）
• 用途別の市場機会

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別の情勢

• 地域別のセグメンテーション
• 地域別の比較
• 北米：市場規模と予測（2021年～2026年）
• 欧州：市場規模と予測（2021年～2026年）
• アジア太平洋：市場規模と予測（2021年～2026年）
• その他の地域（ROW）：市場規模と予測（2021年～2026年）
• 米国：市場規模と予測（2021年～2026年）
• ドイツ：市場規模と予測（2021年～2026年）
• カナダ：市場規模と予測（2021年～2026年）
• ブラジル：市場規模と予測（2021年～2026年）
• 中国：市場規模と予測（2021年～2026年）
• 地域情勢別の市場機会

第8章 促進要因・課題・動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱情勢
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Biotest AG
• Bristol Myers Squibb Co.
• Dynavax Technologies Corp.
• Emergent BioSolutions Inc.
• F. Hoffmann La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Merck and Co. Inc.
• Novartis AG
• Viatris Inc.

第11章 付録

Technavio has been monitoring the hepatitis b therapeutics market and it is poised to grow by $ 471.49 mn during 2022-2026 progressing at a CAGR of 3.29% during the forecast period. Our report on the hepatitis b therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of hepatitis B in infants, growing initiatives to increase awareness about hepatitis B, and growing demand for molecular diagnostics of HBV.

The hepatitis b therapeutics market analysis includes application segment and geographic landscape.

Technavio's hepatitis b therapeutics market is segmented as below:

By Application

• Drugs
• Vaccines

By Geographical Landscape

• North America
• Europe
• APAC
• Rest of World (ROW)

This study identifies the new technological advancements as one of the prime reasons driving the hepatitis b therapeutics market growth during the next few years. Also, a strong pipeline, and increasing awareness and screening programs of HBV diagnostic tests will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hepatitis b therapeutics market covers the following areas:

• Hepatitis b therapeutics market sizing
• Hepatitis b therapeutics market forecast
• Hepatitis b therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis b therapeutics market vendors that include ABIVAX, Biotest AG, Bristol Myers Squibb Co., CASI Pharmaceuticals Inc., Cipla Ltd., Dynavax Technologies Corp., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson, Merck and Co. Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Emergent BioSolutions Inc.. Also, the hepatitis b therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application
• 5.3 Drugs - Market size and forecast 2021-2026
• Exhibit 28: Chart on Drugs - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Drugs - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Drugs - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Drugs - Year-over-year growth 2021-2026 (%)
• 5.4 Vaccines - Market size and forecast 2021-2026
• Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Application
• Exhibit 36: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 APAC - Market size and forecast 2021-2026
• Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 Canada - Market size and forecast 2021-2026
• Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.10 Brazil - Market size and forecast 2021-2026
• Exhibit 70: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Brazil - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
• 7.11 China - Market size and forecast 2021-2026
• Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 Biotest AG
• Exhibit 85: Biotest AG - Overview
• Exhibit 86: Biotest AG - Business segments
• Exhibit 87: Biotest AG - Key offerings
• Exhibit 88: Biotest AG - Segment focus
• 10.4 Bristol Myers Squibb Co.
• Exhibit 89: Bristol Myers Squibb Co. - Overview
• Exhibit 90: Bristol Myers Squibb Co. - Product / Service
• Exhibit 91: Bristol Myers Squibb Co. - Key offerings
• 10.5 Dynavax Technologies Corp.
• Exhibit 92: Dynavax Technologies Corp. - Overview
• Exhibit 93: Dynavax Technologies Corp. - Product / Service
• Exhibit 94: Dynavax Technologies Corp. - Key news
• Exhibit 95: Dynavax Technologies Corp. - Key offerings
• 10.6 Emergent BioSolutions Inc.
• Exhibit 96: Emergent BioSolutions Inc. - Overview
• Exhibit 97: Emergent BioSolutions Inc. - Product / Service
• Exhibit 98: Emergent BioSolutions Inc. - Key news
• Exhibit 99: Emergent BioSolutions Inc. - Key offerings
• 10.7 F. Hoffmann La Roche Ltd.
• Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus
• 10.8 Gilead Sciences Inc.
• Exhibit 105: Gilead Sciences Inc. - Overview
• Exhibit 106: Gilead Sciences Inc. - Product / Service
• Exhibit 107: Gilead Sciences Inc. - Key news
• Exhibit 108: Gilead Sciences Inc. - Key offerings
• 10.9 GlaxoSmithKline Plc
• Exhibit 109: GlaxoSmithKline Plc - Overview
• Exhibit 110: GlaxoSmithKline Plc - Business segments
• Exhibit 111: GlaxoSmithKline Plc - Key news
• Exhibit 112: GlaxoSmithKline Plc - Key offerings
• Exhibit 113: GlaxoSmithKline Plc - Segment focus
• 10.10 Merck and Co. Inc.
• Exhibit 114: Merck and Co. Inc. - Overview
• Exhibit 115: Merck and Co. Inc. - Business segments
• Exhibit 116: Merck and Co. Inc. - Key news
• Exhibit 117: Merck and Co. Inc. - Key offerings
• Exhibit 118: Merck and Co. Inc. - Segment focus
• 10.11 Novartis AG
• Exhibit 119: Novartis AG - Overview
• Exhibit 120: Novartis AG - Business segments
• Exhibit 121: Novartis AG - Key offerings
• Exhibit 122: Novartis AG - Segment focus
• 10.12 Viatris Inc.
• Exhibit 123: Viatris Inc. - Overview
• Exhibit 124: Viatris Inc. - Business segments
• Exhibit 125: Viatris Inc. - Key offerings
• Exhibit 126: Viatris Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 127: Inclusions checklist
• Exhibit 128: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 129: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 130: Research methodology
• Exhibit 131: Validation techniques employed for market sizing
• Exhibit 132: Information sources
• 11.5 List of abbreviations
• Exhibit 133: List of abbreviations

Exhibits

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Application - Market share 2021-2026 (%)
• Exhibits25: Data Table on Application - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Application
• Exhibits27: Data Table on Comparison by Application
• Exhibits28: Chart on Drugs - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Drugs - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Drugs - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Drugs - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Application ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on APAC - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Brazil - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: Biotest AG - Overview
• Exhibits86: Biotest AG - Business segments
• Exhibits87: Biotest AG - Key offerings
• Exhibits88: Biotest AG - Segment focus
• Exhibits89: Bristol Myers Squibb Co. - Overview
• Exhibits90: Bristol Myers Squibb Co. - Product / Service
• Exhibits91: Bristol Myers Squibb Co. - Key offerings
• Exhibits92: Dynavax Technologies Corp. - Overview
• Exhibits93: Dynavax Technologies Corp. - Product / Service
• Exhibits94: Dynavax Technologies Corp. - Key news
• Exhibits95: Dynavax Technologies Corp. - Key offerings
• Exhibits96: Emergent BioSolutions Inc. - Overview
• Exhibits97: Emergent BioSolutions Inc. - Product / Service
• Exhibits98: Emergent BioSolutions Inc. - Key news
• Exhibits99: Emergent BioSolutions Inc. - Key offerings
• Exhibits100: F. Hoffmann La Roche Ltd. - Overview
• Exhibits101: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits102: F. Hoffmann La Roche Ltd. - Key news
• Exhibits103: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits104: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits105: Gilead Sciences Inc. - Overview
• Exhibits106: Gilead Sciences Inc. - Product / Service
• Exhibits107: Gilead Sciences Inc. - Key news
• Exhibits108: Gilead Sciences Inc. - Key offerings
• Exhibits109: GlaxoSmithKline Plc - Overview
• Exhibits110: GlaxoSmithKline Plc - Business segments
• Exhibits111: GlaxoSmithKline Plc - Key news
• Exhibits112: GlaxoSmithKline Plc - Key offerings
• Exhibits113: GlaxoSmithKline Plc - Segment focus
• Exhibits114: Merck and Co. Inc. - Overview
• Exhibits115: Merck and Co. Inc. - Business segments
• Exhibits116: Merck and Co. Inc. - Key news
• Exhibits117: Merck and Co. Inc. - Key offerings
• Exhibits118: Merck and Co. Inc. - Segment focus
• Exhibits119: Novartis AG - Overview
• Exhibits120: Novartis AG - Business segments
• Exhibits121: Novartis AG - Key offerings
• Exhibits122: Novartis AG - Segment focus
• Exhibits123: Viatris Inc. - Overview
• Exhibits124: Viatris Inc. - Business segments
• Exhibits125: Viatris Inc. - Key offerings
• Exhibits126: Viatris Inc. - Segment focus
• Exhibits127: Inclusions checklist
• Exhibits128: Exclusions checklist
• Exhibits129: Currency conversion rates for US$
• Exhibits130: Research methodology
• Exhibits131: Validation techniques employed for market sizing
• Exhibits132: Information sources
• Exhibits133: List of abbreviations